ENZYMATIC BLOOD GLUCOSE— 510(k) K862721

Name: FDA 510(k) clearance K862721
Creator: U.S. Food and Drug Administration
Published: 1986-09-03

Substantially Equivalent

U. S. Diagnostics, Inc.

FDA 510(k) clearance K862721 for ENZYMATIC BLOOD GLUCOSE, Substantially Equivalent on 1986-09-03. Applicant: U. S. Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: U. S. Diagnostics, Inc.
Product code: Code CGA
Device class: Class 2
Regulation: 21 CFR 862.1345
Advisory panel: Clinical Chemistry
Date received: 1986-07-17
Decision date: 1986-09-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Luis Obispo, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CGA

view all

K252488 — ABL90 FLEX PLUS System2026-05-01
K210933 — YSI 2900C Biochemistry Analyzer2024-09-30
K220328 — EasyStat 3002024-07-26
K223179 — Cholestech LDX System2023-09-20
K223755 — i-STAT G cartridge with the i-STAT 1 System2023-09-11

More clearances from U. S. Diagnostics, Inc.

view all

K110435 — EASYGLUCO PLUS BLOOD GLUCOSE MONITORING SYSTEM2011-09-21
K082201 — G5 INFINITY BLODO GLUCOSE MONITORING SYSTEM WITH MODEL IGM, 0024A2009-02-20
K061431 — EASYGLUCO, MODEL IGM-0002 G22007-01-12
K051651 — G4, MODEL IGM-00042006-04-14
K870596 — PROTHROMBIN TIME TEST1987-04-20

Adverse events under product code CGA

product code CGA

Death: 2
Malfunction: 1,816
Total: 1,818

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.